Of note, while radiation therapy-induced immunogenic cell death occurs within 1–3 days in breast tumor cells, anti-tumor immunity to melanoma is improved when anti-CTLA-4 antibody precedes radiation therapy [52, 58, 59]. The gene discussed is CTLA4; the disease is breast neoplasm.